$RGR
STURM RUGER & CO INC

2014 Q1 Form 10-Q Financial Statement

#000117494714000243 Filed on May 05, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $169.9M $155.9M
YoY Change 8.97% 38.78%
Cost Of Revenue $108.8M $94.60M
YoY Change 14.97% 34.1%
Gross Profit $61.12M $61.31M
YoY Change -0.3% 46.7%
Gross Profit Margin 35.98% 39.32%
Selling, General & Admin $23.15M $24.21M
YoY Change -4.35% 39.3%
% of Gross Profit 37.88% 39.48%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.940M $4.501M
YoY Change 98.62% 32.85%
% of Gross Profit 14.63% 7.34%
Operating Expenses $23.15M $24.21M
YoY Change -4.35% 39.3%
Operating Profit $37.97M $37.10M
YoY Change 2.34% 51.96%
Interest Expense -$36.00K -$16.00K
YoY Change 125.0% -30.43%
% of Operating Profit -0.09% -0.04%
Other Income/Expense, Net $329.0K $249.0K
YoY Change 32.13% 60.65%
Pretax Income $38.30M $37.35M
YoY Change 2.54% 52.01%
Income Tax $13.98M $13.63M
% Of Pretax Income 36.5% 36.5%
Net Earnings $24.32M $23.72M
YoY Change 2.53% 53.22%
Net Earnings / Revenue 14.32% 15.21%
Basic Earnings Per Share $1.26 $1.23
Diluted Earnings Per Share $1.22 $1.20
COMMON SHARES
Basic Shares Outstanding 19.37M shares 19.28M shares
Diluted Shares Outstanding 19.90M shares 19.80M shares

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.80M $45.60M
YoY Change 9.21% -52.4%
Cash & Equivalents $49.77M $45.61M
Short-Term Investments
Other Short-Term Assets $12.20M $8.600M
YoY Change 41.86% 8.86%
Inventory $29.14M $14.09M
Prepaid Expenses
Receivables $69.90M $59.48M
Other Receivables $0.00 $0.00
Total Short-Term Assets $161.0M $127.8M
YoY Change 25.98% -20.32%
LONG-TERM ASSETS
Property, Plant & Equipment $101.8M $69.44M
YoY Change 46.68% 32.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $26.52M $11.78M
YoY Change 125.04% 40.29%
Total Long-Term Assets $128.4M $83.67M
YoY Change 53.42% 37.16%
TOTAL ASSETS
Total Short-Term Assets $161.0M $127.8M
Total Long-Term Assets $128.4M $83.67M
Total Assets $289.4M $211.5M
YoY Change 36.84% -4.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $45.40M $41.50M
YoY Change 9.4% 33.44%
Accrued Expenses $26.60M $23.60M
YoY Change 12.71% 122.64%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $86.42M $80.71M
YoY Change 7.07% 54.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $300.0K $19.10M
YoY Change -98.43% -2.05%
Total Long-Term Liabilities $300.0K $19.10M
YoY Change -98.43% -2.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $86.42M $80.71M
Total Long-Term Liabilities $300.0K $19.10M
Total Liabilities $96.50M $99.80M
YoY Change -3.31% 39.39%
SHAREHOLDERS EQUITY
Retained Earnings $205.6M $139.1M
YoY Change 47.85%
Common Stock $20.83M $16.47M
YoY Change 26.45%
Preferred Stock
YoY Change
Treasury Stock (at cost) $37.88M $37.88M
YoY Change 0.0%
Treasury Stock Shares 4.299M shares 4.299M shares
Shareholders Equity $192.8M $111.6M
YoY Change
Total Liabilities & Shareholders Equity $289.4M $211.5M
YoY Change 36.84% -4.48%

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income $24.32M $23.72M
YoY Change 2.53% 53.22%
Depreciation, Depletion And Amortization $8.940M $4.501M
YoY Change 98.62% 32.85%
Cash From Operating Activities $15.71M $30.41M
YoY Change -48.33% 39.22%
INVESTING ACTIVITIES
Capital Expenditures $9.579M $7.705M
YoY Change 24.32% 152.87%
Acquisitions
YoY Change
Other Investing Activities $0.00 $100.0K
YoY Change -100.0% -100.5%
Cash From Investing Activities -$9.579M -$7.635M
YoY Change 25.46% -66.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$11.43M -$8.139M
YoY Change 40.37% 102.41%
NET CHANGE
Cash From Operating Activities $15.71M $30.41M
Cash From Investing Activities -$9.579M -$7.635M
Cash From Financing Activities -$11.43M -$8.139M
Net Change In Cash -$5.294M $14.63M
YoY Change -136.18% -380.27%
FREE CASH FLOW
Cash From Operating Activities $15.71M $30.41M
Capital Expenditures $9.579M $7.705M
Free Cash Flow $6.131M $22.70M
YoY Change -72.99% 20.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-29
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000095029
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19398752 shares
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
STURM RUGER & CO INC
CY2014Q1 dei Trading Symbol
TradingSymbol
RGR
CY2014Q1 rgr Increase Decrease In Prepaid Expense Other Assets And Other Liabilities
IncreaseDecreaseInPrepaidExpenseOtherAssetsAndOtherLiabilities
6618000 USD
CY2013Q1 rgr Increase Decrease In Prepaid Expense Other Assets And Other Liabilities
IncreaseDecreaseInPrepaidExpenseOtherAssetsAndOtherLiabilities
2676000 USD
CY2014Q1 rgr Increase Decrease In Product Liability
IncreaseDecreaseInProductLiability
15000 USD
CY2013Q1 rgr Increase Decrease In Product Liability
IncreaseDecreaseInProductLiability
186000 USD
CY2014Q1 rgr Product Liability Accrual Noncurrent
ProductLiabilityAccrualNoncurrent
283000 USD
CY2013Q4 rgr Product Liability Accrual Noncurrent
ProductLiabilityAccrualNoncurrent
265000 USD
CY2014Q1 rgr Product Liability Current
ProductLiabilityCurrent
968000 USD
CY2013Q4 rgr Product Liability Current
ProductLiabilityCurrent
971000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49770000 USD
CY2014Q1 rgr Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue
7.54
CY2014Q1 rgr Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageGrantDateFairValue
CY2014Q1 rgr Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
6.29
CY2013Q4 rgr Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
6.65
CY2014Q1 rgr Share Based Compensation Cost Related To Restricted Stock
ShareBasedCompensationCostRelatedToRestrictedStock
1200000 USD
CY2013Q1 rgr Share Based Compensation Cost Related To Restricted Stock
ShareBasedCompensationCostRelatedToRestrictedStock
1200000 USD
CY2014Q1 rgr Threshold Limit Of Aggregate Loss For Insurance Coverage On Annual Basis Excluding New Claims From Governments Or Municipalities
ThresholdLimitOfAggregateLossForInsuranceCoverageOnAnnualBasisExcludingNewClaimsFromGovernmentsOrMunicipalities
10000000 USD
CY2014Q1 rgr Threshold Limit Of Losses Per Transaction For Taking Insurance Coverage On Annual Basis
ThresholdLimitOfLossesPerTransactionForTakingInsuranceCoverageOnAnnualBasis
5000000 USD
CY2014Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
45416000 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
46991000 USD
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
69900000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67384000 USD
CY2014Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
13453000 USD
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
239000 USD
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
157854000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
149099000 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19379000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19379000 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
20827000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
20614000 USD
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-2294000 USD
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1214000 USD
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
1344000 USD
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3800000 USD
CY2014Q1 us-gaap Assets
Assets
289373000 USD
CY2013Q4 us-gaap Assets
Assets
277118000 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
161007000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
157626000 USD
CY2014Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0px"> NOTE 1 - BASIS OF PRESENTATION</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0px"> &nbsp;</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0px; TEXT-INDENT: 27pt"> The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America for complete financial statements.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0px"> &nbsp;</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0px; TEXT-INDENT: 27pt"> In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation of the results of the interim periods. Operating results for the three months ended March 29, 2014 may not be indicative of the results to be expected for the full year ending December 31, 2014. These financial statements have been prepared on a basis that is substantially consistent with the accounting principles applied in our Annual Report on Form 10-K for the year ended December 31, 2013.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0px"> &nbsp;</p> <!--EndFragment--></div> </div>
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55064000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45611000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30978000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5294000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14633000 USD
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.540
CY2013Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.404
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
108761000 USD
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
94596000 USD
CY2014Q1 us-gaap Deferred Income Taxes And Other Liabilities Noncurrent
DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
9821000 USD
CY2013Q4 us-gaap Deferred Income Taxes And Other Liabilities Noncurrent
DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
9601000 USD
CY2014Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1680000 USD
CY2013Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2684000 USD
CY2014Q1 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
9537000 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
7637000 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8940000 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4501000 USD
CY2014Q1 us-gaap Dividends Common Stock
DividendsCommonStock
-10475000 USD
CY2014Q1 us-gaap Dividends Paidinkind
DividendsPaidinkind
-346000 USD
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.26
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.23
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.22
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.20
CY2014Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.365 pure
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.365 pure
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
20926000 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
34626000 USD
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1344000 USD
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1747000 USD
CY2014Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
USD
CY2013Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
70000 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8733000 USD
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8443000 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
61123000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
61309000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38298000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37351000 USD
CY2014Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
100000 USD
CY2013Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
400000 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13979000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13633000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1256000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2836000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2516000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16464000 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
13214000 USD
CY2013Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
14133000 USD
CY2014Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-14046000 USD
CY2013Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3678000 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6033000 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1684000 USD
CY2014Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
533533 shares
CY2013Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
517904 shares
CY2014Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-36000 USD
CY2013Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-16000 USD
CY2014Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11722000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6552000 USD
CY2014Q1 us-gaap Inventory Gross
InventoryGross
70620000 USD
CY2013Q4 us-gaap Inventory Gross
InventoryGross
64199000 USD
CY2014Q1 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
38904000 USD
CY2013Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
38516000 USD
CY2014Q1 us-gaap Inventory Net
InventoryNet
29137000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
23261000 USD
CY2014Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2579000 USD
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2422000 USD
CY2014Q1 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
58898000 USD
CY2013Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
57647000 USD
CY2014Q1 us-gaap Inventory Write Down
InventoryWriteDown
157000 USD
CY2013Q1 us-gaap Inventory Write Down
InventoryWriteDown
235000 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
289373000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
277118000 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
86421000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
88166000 USD
CY2012 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
200000 USD
CY2013 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1300000 USD
CY2014Q1 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
5 pure
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11425000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8139000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9579000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7635000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15710000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
30407000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
24319000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
23718000 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
329000 USD
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
249000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
23154000 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
24207000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
37969000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
37102000 USD
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26519000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18464000 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
365000 USD
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
265000 USD
CY2014Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10475000 USD
CY2013Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7804000 USD
CY2014Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2317000 USD
CY2013Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2082000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9579000 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7705000 USD
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2663000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4280000 USD
CY2014Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
CY2013Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
70000 USD
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23000 USD
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
USD
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
259701000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
250127000 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101847000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101028000 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
205586000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
192088000 USD
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
169884000 USD
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
155905000 USD
CY2014Q1 us-gaap Selling Expense
SellingExpense
14421000 USD
CY2013Q1 us-gaap Selling Expense
SellingExpense
15764000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1214000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1330000 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.82
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.66
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2100000 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
40977 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
57221 shares
CY2014Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
16244 shares
CY2014Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
USD
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.25
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2014Q2 us-gaap Share Price
SharePrice
0.49
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
192848000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
179086000 USD
CY2014Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
59330 shares
CY2014Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
4299434 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4299434 shares
CY2014Q1 us-gaap Treasury Stock Value
TreasuryStockValue
37884000 USD
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
37884000 USD
CY2014Q1 us-gaap Use Of Estimates
UseOfEstimates
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0px"> <u>Use of Estimates:</u></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0px"> &nbsp;</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0px; TEXT-INDENT: 27pt"> The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0px"> &nbsp;</p> <!--EndFragment--></div> </div>
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19899484 shares
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19799873 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19365951 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19281969 shares
CY2014Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
5658000 USD
CY2013Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
5339000 USD

Files In Submission

Name View Source Status
0001174947-14-000243-index-headers.html Edgar Link pending
0001174947-14-000243-index.html Edgar Link pending
0001174947-14-000243.txt Edgar Link pending
0001174947-14-000243-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgr-20140329.xml Edgar Link completed
rgr-20140329.xsd Edgar Link pending
rgr-20140329_cal.xml Edgar Link unprocessable
rgr-20140329_def.xml Edgar Link unprocessable
rgr-20140329_lab.xml Edgar Link unprocessable
rgr-20140329_pre.xml Edgar Link unprocessable
rgr031410q.htm Edgar Link pending
rgr031410q_ex31-1.htm Edgar Link pending
rgr031410q_ex31-2.htm Edgar Link pending
rgr031410q_ex32-1.htm Edgar Link pending
rgr031410q_ex32-2.htm Edgar Link pending
Show.js Edgar Link pending